BNTX (BioNTech Inc.) Sof foyda

BNTX (BioNTech) - kompaniyaning tovar belgisi

BioNTech SE (BNTX) moliyaviy natijalari dinamikasi daromadlilik tendentsiyasini aniq namoyish etadi, bunda -1.95 ko'rsatkichi foyda parametrining holatini belgilaydi. BioNTech SE (BNTX) yuqori marjalarni saqlab qolish uchun zamonaviy ta'minot zanjirlari orqali mRNA dori vositalari logistikasini optimallashtirmoqda. Biznesning rivojlanishi klinik sinovlarning muvaffaqiyati va vaksinalarga bo'lgan talabga, shuningdek, o'zining tadqiqot va ishlanmalar (R&D) jarayonlarini tezlashtirish uchun AI startaplarini sotib olishga bog'liq.

BNTX (BioNTech SE) Sof foyda tarixi 04.07.2022dan 29.10.2026gacha

BioNTech (BNTX) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari BioNTech Pharma|BNTX - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi BioNTech Pharma|BNTX - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati BioNTech|BNTX - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi biontech.de|BNTX - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati BioNTech SE|BNTX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati BioNTech Inc.|BNTX - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar BioNTech Pharma|BNTX - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi BioNTech|Shoshilinch likvidlik biontech.de
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
BNTX - Sof foyda
Kompaniyaning jamlanma tahlili:BioNTech SE
BioNTech Group asosiy tovari

Foyda barcha operatsion va soliq xarajatlaridan tashqari yakuniy moliyaviy natijani o'lchaydi va biznesning haqiqiy samaradorligini belgilaydi. BioNTech SE (BNTX) uchun ushbu ko'rsatkich mRNA patentlarini monetizatsiya qilish va to'plangan rezervlardan foydalanish qobiliyatini aks ettiradi. Kompaniyaga tegishli foydani tahlil qilish orqali investor COVID vaksinalaridan saraton terapiyasiga o'tish sur'atini baholaydi. Foyda dinamikasi noyob immun dasturlash platformasining barqarorligini tasdiqlaydi. Ushbu ko'rsatkichning barqaror o'sishi aktivni uzoq muddatli portfel uchun jozibador qiladi.

Asosiy raqobatchilar

Sof daromad argenx BVBA|ABVX (Abivax S.A.) - Sof foyda|Sof foyda admabiologics.com|Sof daromad PTGX (Protagonist)|IMVT (Immunovant Inc) - Yakuniy foyda|Sof foyda KNSA (Kiniksa Pharmaceuticals Ltd)|Sof moliyaviy natija Grifols Biemat (GRFS)|ADPT - Kompaniyaning sof foydasi|celldex.com (CLDX) - Sof daromad|Aurinia Pharmaceuticals Inc. (AUPH) - Kompaniyaning sof foydasi|Sof daromad BioCryst Pharmaceuticals, Inc.|Sof daromad VERA|Sof foyda Dianthus Corp|Kompaniyaning sof foydasi Pharvaris N.V. (PHVS)|AbCellera Biologics Inc. - Kompaniya foydasi|Sof foyda TRML (Tourmaline Bio)|Precigen Inc (PGEN) - Kompaniyaning sof daromadi|Pharming - Sof foyda|NKTR: Kompaniyaning sof foydasi|UPB: Sof foyda|ZBIO - Sof moliyaviy natija|Kompaniyaning sof foydasi Immunome|Kompaniyaning sof daromadi Gossamer Bio Inc GOSS|Kompaniyaning sof foydasi KalVista Pharmaceuticals Inc (KALV)|Septerna Pharma - Kompaniya foydasi|Pieris Pharmaceuticals - Sof daromad|Soliqlar to‘langandan keyingi foyda SVRA (savarapharma.com)|Rigel Pharmaceuticals, Inc. - Sof foyda|Kompaniyaning sof daromadi AnaptysBio Inc|ATXS: Sof foyda|Sof daromad enGene Corp|RAPT (RAPT Therapeutics, Inc.) - Sof foyda|JBIO: Yakuniy foyda|Sof daromad ACRS (Aclaris Therapeutics, Inc.)|KYTX (Kyverna Therapeutics Inc.) - Yakuniy foyda|Kompaniyaning sof foydasi Tiziana Life Sciences PLC TLSA|Sof moliyaviy natija Cabaletta Bio Inc (CABA)|Ventyx Biosciences - Sof foyda|Kompaniyaning sof daromadi theratech.com|AVTX: Sof foyda|ELDN (Eledon Pharmaceuticals Inc.) - Kompaniyaning sof foydasi|Kompaniyaning sof foydasi Agenus Inc|Kompaniya foydasi CLYM (Climb Bio, Inc)|Sof daromad ZURA (Zura Bio Limited)|Soliqlar to‘langandan keyingi foyda ATYR|Adagene Inc. - Sof daromad|IMA: Kompaniya foydasi|STTK - Kompaniyaning sof foydasi|Soliqdan keyingi foyda EQ|CNTB: Sof foyda|Immunic - Yakuniy foyda|ATRA (Atara Biotherapeutics, Inc.) - Sof foyda|Sof foyda InflaRx GmbH|Kompaniyaning sof foydasi X4 Pharma (XFOR)|ACET (adicetbio.com) - Yakuniy foyda|Kompaniyaning sof foydasi Celularity CELU|INMB - Sof daromad|Barinthus Biotherapeutics plc - Sof foyda|KZR - Sof foyda|SABS (SAB Biotherapeutics, Inc) - Sof daromad|Akari Therapeutics, Plc - Yakuniy foyda|ENLV (Enlivex Therapeutics Ltd) - Sof foyda|Q32 Bio Corp (QTTB) - Sof moliyaviy natija|Kompaniyaning sof foydasi GeoVax (GOVX)|Sof daromad Edesa Biotech Inc EDSA|Kompaniyaning sof foydasi iBio Corp IBIO|CARM - Sof daromad|XTLB: Sof daromad|BOLT - Sof foyda|hcwbiologics.com (HCWB) - Kompaniyaning sof foydasi|Kompaniya foydasi APVO|AIM (AIM ImmunoTech) - Sof foyda|Kompaniyaning sof daromadi Aditxt Corp ADTX|Sof foyda GRI|Kompaniyaning sof foydasi XRTX (xortx.com)|Sof foyda HIND (Vyome Holdings)|Sof moliyaviy natija Revelation Biosciences Inc (REVB)|INDP - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi BiondVax Pharmaceuticals|calcimedica.com (CALI) - Kompaniyaning sof foydasi|Kompaniya foydasi AFMD|Sof daromad ALLK|HOOK (HOOKIPA) - Soliqlar to‘langandan keyingi foyda|Sof foyda IGMS|ITOS - Kompaniyaning sof daromadi|Sof foyda OCEA (Ocean Biomedical, Inc.)|TCBP - Sof daromad|Third Harmonic Bio, Inc. - Sof foyda